Scarica l'app Stockscreener
3.92
2.73%
-0.11
Precedente Chiudi:
$4.03
Aprire:
$4.05
Volume 24 ore:
272.51K
Relative Volume:
1.28
Capitalizzazione di mercato:
$94.36M
Reddito:
$52.29M
Utile/perdita netta:
$-73.52M
Rapporto P/E:
-5.9394
EPS:
-0.66
Flusso di cassa netto:
$-100.45M
1 W Prestazione:
-4.39%
1M Prestazione:
-19.34%
6M Prestazione:
-17.12%
1 anno Prestazione:
-12.89%
Intervallo 1D:
$3.8595
$4.0584
Intervallo di 1 settimana:
$3.8595
$4.61
Portata 52W:
$3.8595
$8.82
Precision Biosciences Inc Stock (DTIL) Company Profile
Nome
Precision Biosciences Inc
Settore
Industria
Telefono
919-314-5512
Indirizzo
302 EAST PETTIGREW STREET, DURHAM, NC
Confronta DTIL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
3.92 | 97.01M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | Iniziato | Guggenheim | Buy |
| 2022-06-17 | Iniziato | BMO Capital Markets | Outperform |
| 2022-06-09 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | Ripresa | BTIG Research | Buy |
| 2020-04-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-03-05 | Iniziato | Stifel | Buy |
| 2020-02-25 | Iniziato | William Blair | Outperform |
| 2019-08-09 | Iniziato | BTIG Research | Buy |
| 2019-07-16 | Iniziato | H.C. Wainwright | Buy |
| 2019-04-22 | Iniziato | Barclays | Overweight |
| 2019-04-22 | Iniziato | Goldman | Buy |
| 2019-04-22 | Iniziato | JP Morgan | Overweight |
| 2019-04-22 | Iniziato | Jefferies | Buy |
Mostra tutto
Precision Biosciences Inc Borsa (DTIL) Ultime notizie
Can Precision BioSciences Inc. (PBS0) stock deliver strong annual returnsMarket Volume Summary & Momentum Based Trading Ideas - ulpravda.ru
Can Precision BioSciences Inc. stock reach $100 price targetJuly 2025 Price Swings & Verified Swing Trading Watchlists - ulpravda.ru
Is Precision BioSciences Inc. stock a top pick in earnings seasonEarnings Performance Report & AI Driven Price Forecasts - ulpravda.ru
How Precision BioSciences Inc. stock compares to market leadersWeekly Market Outlook & Smart Swing Trading Techniques - ulpravda.ru
Can Precision BioSciences Inc. stock hit analyst price targetsQuarterly Trade Review & Low Drawdown Investment Ideas - ulpravda.ru
Is Precision BioSciences Inc. (PBS0) stock a top hedge fund pickIPO Market Watch & Free High Yield Investment Strategies - ulpravda.ru
Precision BioSciences: Tiny Gene-Editing Stock Caught Between Deep Cuts and Big Optionality - AD HOC NEWS
Precision Bio's DMD Therapy Gets Rare Pediatric Status, But Stock Slides; Retail Crowd Sees ‘Good Risk-Reward’ - MSN
What drives Precision BioSciences Inc PBS0 stock priceSell Signals and Alerts & Low Cost Portfolio Tips - earlytimes.in
Sterling Tools Limited Ranks High in Smart Money TrackerFundamental Strength Indicators & Explosive Profit Growth - earlytimes.in
Aug Ideas: Is Precision BioSciences Inc stock a top pick in earnings season - moha.gov.vn
Short Interest in Precision BioSciences, Inc. (NASDAQ:DTIL) Expands By 27.4% - MarketBeat
Earnings Update: Is Precision BioSciences Inc stock a top pick in earnings seasonWeekly Earnings Recap & Consistent Profit Trading Strategies - moha.gov.vn
Precision Biosciences Inc files for mixed shelf of up to $250 millionSEC filing - MarketScreener
Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - Seeking Alpha
Will Precision BioSciences Inc. stock benefit from infrastructure spendingMarket Breadth Indicators & Investor Community Interactions - bollywoodhelpline.com
Can Precision BioSciences Inc. stock maintain operating marginsEarnings Volatility Patterns & Affordable Stock Picks - bollywoodhelpline.com
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - 01net
What analysts say about Precision BioSciences Inc PBS0 stockInstitutional Buying Trends & Free Explosive Trading Growth - earlytimes.in
Precision BioSciences Earnings Notes - Trefis
Will Precision BioSciences Inc. stock gain from government policies2025 Price Targets & Free Safe Capital Growth Stock Tips - Улправда
How Precision BioSciences Inc. stock compares to industry benchmarksWeekly Investment Summary & Weekly Watchlist for Consistent Profits - Улправда
How Precision BioSciences Inc. stock reacts to global recession fearsNew Guidance & Technical Pattern Based Buy Signals - DonanımHaber
Market Recap: How Precision BioSciences Inc. stock reacts to global recession fears2025 Price Targets & Scalable Portfolio Growth Methods - DonanımHaber
Will Precision BioSciences Inc. stock outperform Nasdaq indexIPO Watch & Daily Oversold Bounce Ideas - Улправда
Aug Shorts: Will Precision BioSciences Inc. stock benefit from infrastructure spendingPortfolio Update Report & Free Technical Pattern Based Buy Signals - Улправда
Street Watch: Is Precision BioSciences Inc. (PBS0) stock a top hedge fund pick2025 Key Highlights & Daily Profit Maximizing Tips - ulpravda.ru
Precision BioSciences (NASDAQ:DTIL) Director Geno Germano Buys 3,000 Shares - MarketBeat
Insider Buying: Stanley Frankel Acquires Additional Shares of Pr - GuruFocus
Insider Buying: Precision BioSciences (NASDAQ:DTIL) Director Acquires $12,690.00 in Stock - MarketBeat
Dir Germano Buys 3,000 ($14.2K) Of Precision BioSciences Inc [DTIL] - TradingView — Track All Markets
Dir Brown Buys 1,381 ($6.9K) Of Precision BioSciences Inc [DTIL] - TradingView — Track All Markets
Precision Biosciences Executives Increase Holdings - TradingView — Track All Markets
Precision Biosciences (DTIL) director adds 3,000 shares in open-market buy - Stock Titan
Precision BioSciences (DTIL) director reports purchase of 2,700 shares - Stock Titan
Precision BioSciences (DTIL) director reports purchase of 1,381 shares - Stock Titan
Financial Analysis: Precision BioSciences (NASDAQ:DTIL) & Upstream Bio (NASDAQ:UPB) - Defense World
Precision BioSciences (DTIL) Receives a Rating Update from a Top Analyst - The Globe and Mail
Aug Summary: Can Precision BioSciences Inc stock hit analyst price targetsWeekly Trading Summary & Reliable Breakout Stock Forecasts - moha.gov.vn
Sidoti Events, LLC's Year-End Virtual Investor Conference - Yahoo Finance
Solid Biosciences to Showcase Proprietary Next-Generation Capsid AAV-SLB101 and Cardiac Gene Therapy Pipeline at the 22nd Global CardioVascular Clinical Trialists (CVCT) Forum - GlobeNewswire
Block Trades: Is Precision BioSciences Inc stock resilient to inflationBuy Signal & Comprehensive Market Scan Reports - BỘ NỘI VỤ
Precision BioSciences launches $75M stock and warrant offering - MSN
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), MBX Biosciences, Inc. (MBX) and Praxis Precision Medicines (PRAX) - The Globe and Mail
Is Precision BioSciences Inc. stock resilient to inflationJuly 2025 Decliners & Consistent Return Strategy Ideas - Newser
Can Precision BioSciences Inc. (PBS0) stock ride next bull market cycleWeekly Trading Summary & AI Enhanced Trading Signals - Newser
Precision Biosciences: Still Swinging And Finally Drawing Blood (NASDAQ:DTIL) - Seeking Alpha
Why Precision BioSciences Inc. (PBS0) stock is a strong buy callJuly 2025 Fed Impact & Growth Focused Entry Point Reports - Newser
How Precision BioSciences Inc. stock reacts to oil pricesQuarterly Profit Review & Reliable Breakout Forecasts - Newser
Precision Biosciences Inc Azioni (DTIL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):